New Insights Into Systemic Lupus Erythematosus Therapies 2010-2020

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that may affect every organ. The multiple pathogenic mechanisms and heterogeneous phenotypes of SLE present unique challenges in the management of this complex disease. This article discusses new SLE therapies from the last 10 years. We will address new information in the realms of lifestyle interventions, antimalarials, nonsteroidal anti-inflammatory drugs, glucocorticoids, immunosuppressive disease modifying antirheumatic drugs, biological therapies, and other modalities as they pertain to SLE.

Automated summary

This article discusses new therapies for systemic lupus erythematosus (SLE) in the past 10 years, including lifestyle interventions, medication treatments, and other modalities.